Evidence map›Paper›PMID 32217610›Full record

ArticleDiabetes2020

Central K

Michelle Carey, Eric Lontchi-Yimagou, William Mitchell, Sarah Reda, Kehao Zhang, Sylvia Kehlenbrink, Sudha Koppaka, Sylvan Roger Maginley, Sandra Aleksic, Shobhit Bhansali and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Michelle CareyAlbert Einstein College of Medicine, Bronx, NY.
Eric Lontchi-YimagouAlbert Einstein College of Medicine, Bronx, NY.
William MitchellAlbert Einstein College of Medicine, Bronx, NY.
Sarah RedaAlbert Einstein College of Medicine, Bronx, NY.
Kehao ZhangAlbert Einstein College of Medicine, Bronx, NY.
Sylvia KehlenbrinkBrigham and Women's Hospital, Harvard Medical School, Boston, MA.
Sudha KoppakaAlbert Einstein College of Medicine, Bronx, NY.
Sylvan Roger MaginleyAlbert Einstein College of Medicine, Bronx, NY.
Sandra AleksicAlbert Einstein College of Medicine, Bronx, NY.
Shobhit BhansaliAlbert Einstein College of Medicine, Bronx, NY.
Derek M HuffmanAlbert Einstein College of Medicine, Bronx, NY.
Meredith HawkinsAlbert Einstein College of Medicine, Bronx, NY meredith.hawkins@einsteinmed.org.ORCID 0000-0003-3121-010X
Albert Einstein College of Medicine · USBrigham and Women's Hospital · US

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI STEVEN C. ALMO · 1985 to 2026
$111.2M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
CTSA Administrative Supplement for Informatics Core: A novel AI/ML system to predict respiratory failure and ARDS in Covid-19 patientsUL1TR002556 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, KIM, MIMI Y · 2018 to 2022
$26.7M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Einstein's Nathan Shock Center of Excellence in Basic Biology of AgingP30AG038072 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HUFFMAN, DEREK MAJOR · 2010 to 2024
$10.8M
Role of Hepatic Fat Metabolism in Glucose EffectivenessR01DK069861 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HAWKINS, MEREDITH A, ROUTH, VANESSA H · 2006 to 2025
$7.6M
Mechanisms of Hypoglycemia Associated Autonomic FailureR01DK079974 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI HAWKINS, MEREDITH A · 2008 to 2017
$3.8M
BIOCHEMICAL MECHANISMS OF IN VIVO INSULIN RESISTANCER01DK048321 · NIDDK · YESHIVA UNIVERSITY · PI HAWKINS, MEREDITH A · 1994 to 2008
$3.1M
Biochemical Mechanisms of In Vivo Insulin ResistanceR37DK048321 · NIDDK · ALBERT EINSTEIN COL OF MED YESHIVA UNIV · PI ROSSETTI, LUCIANO · 2004 to 2005
$911k
Regulation of Hepatic Glucose FluxesR56DK069861 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI HAWKINS, MEREDITH A · 2012 to 2012
$167k
NCATS NIH HHS UL1 TR001073NCATS NIH HHS UL1 TR002556NCI NIH HHS P30 CA013330NIA NIH HHS P30 AG038072NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK048321NIDDK NIH HHS R01 DK069861NIDDK NIH HHS R01 DK079974NIDDK NIH HHS R37 DK048321NIDDK NIH HHS R56 DK069861
6 · The paper itself

Abstract

Hyperglycemia is a potent regulator of endogenous glucose production (EGP). Loss of this "glucose effectiveness" is a major contributor to elevated plasma glucose concentrations in type 2 diabetes (T2D). K

Indexed as

AdultAnimalsBlood GlucoseDiazoxideDrug InteractionsFemaleGene Expression RegulationGlucoseGlucose Clamp TechniqueGlyburideHumansHypoglycemic AgentsKATP ChannelsMaleMiddle AgedRatsBlood GlucoseDiazoxideGlucoseGlyburideHypoglycemic AgentsKATP Channels

Identifiers

PMID32217610
PMCPMC7243288
OpenAlexW3013366598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.